Literature DB >> 28149013

Association of Single Nucleotide Polymorphisms of Adiponectin Gene with Type 2 Diabetes Mellitus, and Their Influence on Cardiovascular Risk Markers.

A A Momin1, M P Bankar2, G M Bhoite3.   

Abstract

Type 2 diabetes mellitus is a genetically heterogeneous condition, characterized by insulin deficiency and/or insulin resistance. The etiology of type 2 diabetes is complex, with involvement of genetic and environmental factors. The adipose tissue protein 'adiponectin' is known to increase insulin sensitivity with decreased risk of type 2 diabetes mellitus. The gene for adiponectin is present on chromosome 3q27, the association of number of single nucleotide polymorphisms of adiponectin gene with type 2 diabetes and its complications have been reported. In the present study the two most common SNPs +45T/G & +276G/T, and their association with type 2 diabetes mellitus and cardiovascular markers were studied. The significant difference in genotype frequencies of +45T/G & +276G/T was found in type 2 diabetic patients and controls, with odds ratio of 1.13 & 1.26 respectively. BMI, Fasting blood glucose, fasting insulin, HOMA IR, triglyceride and VLDL cholesterol levels were increased, and HDL cholesterol level was decreased in patients carrier for +45T/G SNP than the wild type. While only decrease in the HDL cholesterol was reported in carriers for SNP +276G/T than the wild type. The logistic regression analysis revealed the positive association of SNP +45T/G with total cholesterol & LDL cholesterol. And negative association of HDL cholesterol was found with SNPs +45T/G and +276G/T. The haplotype analysis shows the alterations in means of biochemical markers in the patients having haplotype (GG) for mutant allele of SNP +45T/G and wild allele for SNP +276G/T.

Entities:  

Keywords:  Adiponectin; Adiponectin gene; SNP+276G/T; SNP+45T/G; Type 2 diabetes mellitus

Year:  2016        PMID: 28149013      PMCID: PMC5247371          DOI: 10.1007/s12291-016-0573-x

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  27 in total

Review 1.  Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs.

Authors:  A S Krolewski; J H Warram; M B Freire
Journal:  Endocrinol Metab Clin North Am       Date:  1996-06       Impact factor: 4.741

2.  Association of adiponectin gene functional polymorphisms (-11377C/G and +45T/G) with nonalcoholic fatty liver disease.

Authors:  Abhishak Chandra Gupta; Richa Misra; Puja Sakhuja; Yogendra Singh; Seemi Farhat Basir; Shiv Kumar Sarin
Journal:  Gene       Date:  2011-12-29       Impact factor: 3.688

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

5.  The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

Authors:  Jelena Zacharova; Jean-Louis Chiasson; Markku Laakso
Journal:  Diabetes       Date:  2005-03       Impact factor: 9.461

6.  The promoter region of the adiponectin gene is a determinant in modulating insulin sensitivity in childhood obesity.

Authors:  Antonio Petrone; Sara Zavarella; Assunta Caiazzo; Gaetano Leto; Marialuisa Spoletini; Stella Potenziani; John Osborn; Andrea Vania; Raffaella Buzzetti
Journal:  Obesity (Silver Spring)       Date:  2006-09       Impact factor: 5.002

7.  Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays.

Authors:  G R Warnick; M Nauck; N Rifai
Journal:  Clin Chem       Date:  2001-09       Impact factor: 8.327

8.  The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes.

Authors:  Eun Seok Kang; So Young Park; Hyeong Jin Kim; Chul Woo Ahn; Moonsuk Nam; Bong Soo Cha; Sung Kil Lim; Kyung Rae Kim; Hyun Chul Lee
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

Review 9.  The emerging genetic architecture of type 2 diabetes.

Authors:  Alessandro Doria; Mary-Elizabeth Patti; C Ronald Kahn
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

10.  ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity.

Authors:  Nabila Bouatia-Naji; David Meyre; Stéphane Lobbens; Karin Séron; Frédéric Fumeron; Beverley Balkau; Barbara Heude; Béatrice Jouret; Philipp E Scherer; Christian Dina; Jacques Weill; Philippe Froguel
Journal:  Diabetes       Date:  2006-02       Impact factor: 9.461

View more
  1 in total

1.  Curcumin protects islet cells from glucolipotoxicity by inhibiting oxidative stress and NADPH oxidase activity both in vitro and in vivo.

Authors:  Jing Li; Ninghua Wu; Xiao Chen; Hongguang Chen; Xiaosong Yang; Chao Liu
Journal:  Islets       Date:  2019-11-21       Impact factor: 2.694

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.